Surgical Removal of Implant Body Template

Implant removal - by report.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Implant site: #Tooth number(s)
Implant system: Implant system
Reason for removal: Reason for removal

Implant removal support: Original placement date, implant system/site, reason for removal
Removal method/support: Reverse torque/trephine/flap/bone removal details
Graft/replacement plan: Site grafting, healing, and replacement plan if applicable
Radiographs/CBCT/photos: Pre-op/post-op images and findings
Failed integration.
Peri-implantitis.
Malposition.
Fracture.

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Procedure:
Incision made.
Mucoperiosteal flap elevated.
Implant exposed.
Implant removed with reverse torque/trephine.
Socket debrided.
Site evaluated for grafting.
Flap repositioned.
Sutured with: Suture material/size
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Rx: Prescription or none

NV: Next visit

Documentation requirements

A defensible D6100 chart note proves four things: (1) the implant had failed (the failure cause is named and supported by objective findings), (2) non-surgical alternatives were considered or had been exhausted, (3) the removal was performed with appropriate technique, and (4) the site was managed and the replacement plan was discussed with the patient. Include:

• Medical history review and update — meds, conditions, allergies, ASA status, anticoagulant status, bisphosphonate / anti-resorptive history (MRONJ risk on explant surgery is real; document drug, dose, route, duration, and any drug holiday), diabetes / A1C (poor glycemic control is a major peri-implantitis driver), smoking status (smoking is the most consistent peri-implantitis risk factor in the AAP / EFP literature), bruxism / parafunction (occlusal overload as failure cause), and history of head/neck radiation.
• Pre-op vitals — BP, pulse; SpO2 and temperature when indicated, particularly with active infection.
• Implant history — original placement date (or best estimate), original placing provider and practice, implant system / manufacturer / line / diameter / length / lot if available from prior records or scanned implant card. This is the highest-yield audit field on a D6100 note. Carriers, defense counsel, and any future provider will want to know what was placed, when, by whom, and what restorative history followed (when was it loaded, what prosthesis, when did symptoms start). A retrieved implant card or scanned records page attached to the chart is industry best practice.
• Site / tooth number — the Universal tooth position the implant occupies (e.g., #19, #30). State the position even when the implant is unrestored or the position is edentulous.
• Chief complaint — patient's words when applicable ("the implant feels loose," "the gum keeps bleeding around the back tooth implant," "my tooth on the implant just broke off"). Asymptomatic peri-implantitis discovered at recall is documented as a clinical finding rather than a CC.
• Reason for removal — name the failure cause specifically. This is the single most important clinical field on a D6100 note. Acceptable failure-cause language:
  • Failed osseointegration with mobility (Class I / II / III), painless mobility on torque test, no clinical signs of infection
  • Peri-implantitis with probing depths, BOP / suppuration, mobility status, and radiographic bone loss measured against the implant platform or a baseline radiograph
  • Implant fracture at the body / connection / abutment screw level, with photographic and radiographic documentation
  • Malposition precluding restoration, with the specific restorative limitation named (e.g., "implant angulation 25 deg facial of the long axis of the planned restoration; non-restorable with 17-deg angled-screw channel," "implant placed 4 mm subcrestal of the planned occlusal plane; non-restorable")
  • Biologic complication — sinus penetration with chronic sinusitis, IAN paresthesia, recurrent infection, fistula
  • Occlusal overload as contributing factor — opposing natural dentition, parafunction, cantilever loading
  • Patient-driven removal for clinical reasons (e.g., MRI compatibility for an implant in a position causing imaging artifact). Document the conversation, alternatives, and consent.
  • Generic "implant failed" or "patient wants implant out" without supporting findings is a known recoupment trigger.
• Pre-removal objective findings — probing depths around the implant (typically six points), bleeding on probing, suppuration, mobility (Class 0 / I / II / III), occlusal contacts on the prosthesis if loaded, plaque / calculus / cement remnants, soft-tissue color and contour, keratinized tissue width. Patient-specific findings, not "WNL" autotext.
• Imaging — pre-op PA and / or CBCT showing bone loss pattern (crater, dehiscence, fenestration, vertical, horizontal), proximity to vital structures (IAN canal, mental foramen, sinus floor, adjacent roots), and any indication of fracture line. State the diagnostic-quality finding — "PA #19 reveals 6 mm vertical bone loss along the mesial of the fixture, extending past the apical-most thread on mesial, with a crater-shaped radiolucency consistent with peri-implantitis" reads very differently from "PA taken." CBCT is increasingly the standard for D6100 planning when bone loss approaches a vital structure or when 3D angulation is in question.
• Alternatives considered and the patient's choice — non-surgical peri-implant therapy (mechanical debridement with titanium or PEEK instruments, air-abrasion, antimicrobial irrigation), surgical peri-implant therapy (open-flap debridement, implantoplasty, regenerative grafting around the retained implant), or no treatment. Document why those alternatives were not pursued or had failed. PARQ on replacement timeline (the standard 4-6 month healing window before re-implantation, with augmentation healing typically 4-9 months depending on the graft) and on the financial and biologic cost of failure recurrence.
• Anesthesia — agent, concentration, vasoconstrictor, carpules, technique (infiltration, IANB, mental, PSA, etc.). Vasoconstrictor avoidance documentation when relevant (severe cardiac history, MAOI use).
• Removal technique — name what was actually done. Reverse-torque attempt and the torque value applied (e.g., "counter-torque applied to 250 Ncm with Neo IRT-2 driver, fixture released at approximately 200 Ncm"), trephine bur with size and depth (e.g., "5.5 mm trephine bur to a depth of approximately 8 mm to score circumferential bone around the fixture before counter-torque delivery"), or flap and conservative bone removal with technique named. State the bone-conservation rationale ("trephine was sized 0.5 mm larger than the implant diameter to minimize bone sacrifice and preserve the buccal plate for site grafting"). This is the field that distinguishes a defensible D6100 from a generic "removed implant" note.
• Bone preservation considered — buccal-plate integrity at delivery, residual ridge dimension, defect morphology (1- / 2- / 3- / 4-wall), whether site grafting (D7953) is being performed today or staged. The chart note must reflect that bone preservation was a clinical priority, not an afterthought.
• Site management — granulation-tissue debridement (curettes, ultrasonic, rotary), irrigation (saline, chlorhexidine 0.12%, sterile saline rinse), inspection of socket walls for residual implant debris (titanium fragments are common after trephine and must be debrided to prevent foreign-body response), and evaluation for grafting.
• Concurrent grafting — when grafting is performed same-day, document under D7953 (or D7950 if extensive autogenous augmentation) with material name, manufacturer, lot, volume, and membrane (collagen, PTFE, PRF) — billed and documented separately from D6100.
• Closure — flap repositioning, suture material and size (e.g., "3-0 PTFE in interrupted fashion"), primary closure achieved or tension-free closure with releasing incisions, hemostasis confirmed.
• Complications — explicitly noted, even if "none." Common items on D6100: residual titanium fragments, buccal-plate fracture during delivery, sinus communication on a maxillary posterior site, IAN paresthesia on a mandibular posterior site, soft-tissue tearing of an attempted flap.
• Patient tolerance — patient-specific, not autotext. Include sedation status if used (D9230 nitrous, D9243 IV moderate, etc., billed separately).
• Post-op instructions — verbal and written, return precautions (swelling, bleeding, paresthesia, fever, suture loss), diet restrictions, oral hygiene around the surgical site, smoking cessation reinforcement when relevant, and the schedule for suture removal.
• Prescriptions — antibiotic when indicated (peri-implantitis cases, immunocompromised patients, sinus communication, large-volume grafting), analgesic regimen, chlorhexidine rinse if used.
• Replacement timeline / consent for next phase — the chart should reflect that the patient was counseled on the typical 4-6 month soft-tissue / hard-tissue healing window before re-implantation (longer with augmentation), the possibility of further grafting at the implant placement appointment, and the option to defer implant replacement entirely in favor of a fixed bridge or no replacement. PARQ on replacement timeline is a documentation requirement on this code, not a nice-to-have — failure-mode prevention starts with the conversation about why the first implant failed and what is being changed for the second attempt.
• Provider signature, assistant initials, and consent form reference.

The "amnesia test" applies: a third party reading the note must be able to reconstruct (1) why this implant was removed, (2) how it was removed, (3) what was done with the site, and (4) what the patient was told about the next phase. Default-normal autotext ("implant removed atraumatically, site grafted, patient tolerated well") is a recurring recoupment pattern in carrier audits of D6100 claims, and the AAP / AAOMS / ACP literature on implant failure all point to the failure-cause documentation as the single highest-yield clinical and medico-legal field.

Common denial reasons

The most common reasons D6100 is denied, downgraded, or recouped:

• No narrative attached. D6100 is a "by report" code; carriers will not adjudicate without a description of the failure cause and the removal technique. The single most preventable denial on this code.
• Generic failure-cause language. "Implant failed" or "patient wants implant out" without supporting findings (probing depths, bone loss measurement, mobility class, fracture description) reads to a reviewer as elective and is a known recoupment trigger. State the diagnosis specifically.
• No pre-op image. Most carriers require a pre-op PA, pano, or CBCT showing the implant in situ. A claim without imaging pends for records.
• Implant placed by another office without records access. Carrier asks for the original placement date / system / lot and the office cannot provide it. Document what the patient reports, attach any retrieved records, and state explicitly in the narrative that the original placement records were unavailable.
• Same-day conflict with D6190 (implant index). D6190 is a prosthetic verification step on a retained implant; submitting both on the same DOS will typically deny D6190 as inconsistent with a same-day removal. Choose the code that describes the actual procedure.
• Same-day reline / repair codes on an unrelated prosthesis — ensure each code is supported by separate documentation; auditors look for cross-procedure narrative reuse.
• Default-normal templating across many D6100 claims — every chart note in the practice reads identically ("reverse-torque, no complications, grafted, tolerated well") with no patient-specific findings. State Medicaid OIG audits cite this pattern as evidence of fabricated documentation and recoup retroactively.
• Missing tooth / site number on the claim. D6100 is site-specific; the claim must name the position even if the implant was unrestored.
• No anesthesia documentation. Surgical removal of an integrated implant without anesthesia documentation is a flag; carriers and audit programs expect at least local anesthesia documentation on a D6100 claim.
• Removal coded D6100 when only a component was removed. Healing abutment, cover screw, prosthetic abutment, or implant-retained crown removal does not qualify for D6100. The implant body itself must have been removed. This is one of the most common wrong-code denials on this family.
• Bundled-into-replacement denial. Some carriers attempt to bundle D6100 into a same-day or near-term D6010 placement, treating the explant as part of the replacement procedure. Submit with separate narrative and appeal with the ADA position that D6100 and D6010 are distinct procedures.
• Plan does not cover implants. D6100 may be denied as not-a-covered-benefit on plans without an implant rider. Verify implant coverage before scheduling and obtain financial consent.
• Frequency exceeded on the corresponding D6010 lookback. A second D6010 on the same site within the carrier's lookback may be denied or alternate-benefited, even when the D6100 itself is covered. Counsel the patient on the financial implications before scheduling the explant.
• MRONJ risk inadequately documented. Patient on bisphosphonates or other anti-resorptive therapy without documented risk discussion, drug holiday consideration, and informed consent — a defensibility flag on any surgical procedure but particularly on implant-bed surgery.
• No replacement-timeline counseling documented. Carriers and defense counsel both expect to see the PARQ conversation about the typical 4-6 month healing window before re-implantation (longer with augmentation). A note that ends at "implant removed, NV in 1 week" without a replacement plan reads as incomplete.

Related templates